Alignment Healthcare (NASDAQ:ALHC) Insider Sells $237,885.56 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Hyong Kim sold 12,694 shares of the stock in a transaction on Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $237,885.56. Following the completion of the transaction, the insider owned 349,639 shares in the company, valued at $6,552,234.86. The trade was a 3.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Hyong Kim also recently made the following trade(s):

• On Thursday, October 9th, Hyong Kim sold 51,379 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.57, for a total value of $902,729.03.
• On Wednesday, October 8th, Hyong Kim sold 33,655 shares of Alignment Healthcare stock. The shares were sold at an average price of $17.29, for a total value of $581,894.95.

Alignment Healthcare Trading Up 1.6%

Alignment Healthcare stock traded up $0.30 during mid-day trading on Tuesday, hitting $19.24. The stock had a trading volume of 2,308,291 shares, compared to its average volume of 3,029,631. The stock has a 50-day simple moving average of $18.18 and a two-hundred day simple moving average of $16.19. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The stock has a market capitalization of $3.85 billion, a PE ratio of -160.33 and a beta of 1.16. Alignment Healthcare, Inc. has a 12 month low of $11.01 and a 12 month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The company had revenue of $993.70 million for the quarter, compared to the consensus estimate of $980.90 million. During the same period in the prior year, the company posted ($0.14) EPS. The company’s revenue was up 43.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Larson Financial Group LLC bought a new stake in shares of Alignment Healthcare during the third quarter worth $33,000. SBI Securities Co. Ltd. raised its holdings in shares of Alignment Healthcare by 4,868.9% in the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after purchasing an additional 2,970 shares during the last quarter. KBC Group NV bought a new stake in shares of Alignment Healthcare in the second quarter worth $44,000. Signaturefd LLC boosted its holdings in Alignment Healthcare by 142.6% during the second quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after purchasing an additional 2,215 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in Alignment Healthcare in the third quarter valued at $53,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. JPMorgan Chase & Co. upped their price objective on Alignment Healthcare from $20.00 to $23.00 and gave the company an “overweight” rating in a report on Wednesday, December 17th. Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a research report on Monday, November 24th. The Goldman Sachs Group restated a “buy” rating and set a $22.00 price objective on shares of Alignment Healthcare in a report on Monday, November 3rd. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $20.35.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.